Bandingkan Harga & Kinerja Indofood Sukses Makmur Tbk. (INDF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indofood Sukses Makmur Tbk. dan Organon Pharma Indonesia Tbk.: Indofood Sukses Makmur Tbk. diperdagangkan di Rp7.300 (kapitalisasi pasar 64,32 T, volume 24 jam 4,99 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indofood Sukses Makmur Tbk. jauh lebih besar — sekitar 616,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INDF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 64,32 T | 104,4 M |
Volume | 4,99 jt | — |
Lot | 49,94 rb | — |
Perputaran | 36,44 M | — |
Harga Rata-rata | 7.296,53 | — |
Nilai Transaksi | 36,44 M | — |
Harga Ekuilibrium Indikatif | 7.300 | — |
Volume Ekuilibrium Indikatif | 8,08 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indofood Sukses Makmur Tbk.
PT Indofood Sukses Makmur Tbk was established on August 14, 1990 under its original name PT Panganjaya Intikusuma. The Ministry of Justice in its decision letter dated July 12, 1991 approved the deed of establishment. The company’s articles of association has been amended from time to time, the latest of which was covered by notarial deed No. 149 of the same notary dated June 24, 1997 concerning, among others, the increase in the company’s authorized capital stock, the change in the company’s name from PT Indofood Sukses Makmur to PT Indofood Sukses Makmur Tbk, and the change in the company’s corporate life from limited to unlimited period. The Company started its commercial operations in 1990. The company’s shares are listed in the Jakarta and Surabaya Stock Exchanges.
Selengkapnya di halaman INDF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
